The data regarding birth weight offers a striking illustration of this trend. At the beginning of the study period in 2012, children born with a low birth weight were 54% more likely to later receive an ADHD or ASD diagnosis compared to those born at a normal weight. By the end of the study period in 2022, this disparity had shrunk dramatically; the increased likelihood for children with low birth weight had dropped to just 17%.
This pattern of decline was not limited to birth complications. The researchers observed comparable trends across several measures of socioeconomic status. In the past, children from lower-income households or those whose parents had limited formal education were diagnosed at significantly higher rates than their more affluent peers. Over the ten-year period, however, the "socioeconomic gradient" flattened. The population receiving diagnoses today is much more diverse in terms of wealth and education, increasingly reflecting the broad middle and upper-middle classes of the general population.
"The key message is not that these risk factors are no longer important," explained Magnus Elias Tarp, a PhD student at Aarhus University and the first author of the study. Tarp emphasized that while biological and environmental factors still play a role in neurodevelopment, their predictive power has softened. "What we found is that people diagnosed in recent years resemble the general population more closely than those who received the same diagnoses a decade ago."
This suggests that the "diagnostic net" is being cast much wider. In the past, the system primarily caught those with the most obvious risk factors or the most severe symptoms. Today, children who come from stable socioeconomic backgrounds and who had healthy births are being identified at rates that are beginning to match those of more traditionally "high-risk" groups.
A different way to understand rising diagnoses
For years, the scientific community and the public have debated the causes behind the "autism epidemic" and the explosion of ADHD cases. Much of this research has focused on searching for new environmental toxins, changes in diet, or other external factors that might be causing a genuine increase in the underlying occurrence of these conditions.
The ISGlobal and Aarhus University study approaches the trend from a different direction. Rather than asking why more people have these conditions, it asks how the population receiving the labels has changed. This shift in perspective is crucial for understanding the modern healthcare landscape.
The researchers pointed to several developments that have likely contributed to this demographic shift. First and foremost is the massive increase in public and professional awareness. Over the last decade, teachers, parents, and primary care physicians have become much more adept at recognizing the subtle signs of neurodivergence. What might have been dismissed as "shyness" or "disruptive behavior" ten years ago is now more likely to be recognized as a potential symptom of ASD or ADHD.
Furthermore, healthcare and education systems have become more efficient at screening and identification. In many regions, schools have implemented more robust support systems that include early screening for learning and behavioral differences. Access to specialized diagnostic evaluations has also expanded, allowing families who might not have had the resources or the "clinical urgency" in the past to seek out a formal assessment.
Perhaps most importantly, the researchers suggest that the "clinical threshold" for diagnosis may have shifted. The point at which a child’s neurodevelopmental characteristics are considered "clinically impairing" is not a fixed line; it is a judgment call made by clinicians based on evolving diagnostic criteria and societal expectations. As society becomes more attuned to the needs of neurodivergent individuals, the bar for what constitutes a "impairment" that warrants a diagnosis may have lowered, bringing more individuals with milder presentations into the clinical population.
